Synthesis and Antidepressant Activity Profile of Some Novel Benzothiazole Derivatives

Within the scope of our new antidepressant drug development efforts, in this study, we synthesized eight novel benzothiazole derivatives - . The chemical structures of the synthesized compounds were elucidated by spectroscopic methods. Test compounds were administered orally at a dose of 40 mg/kg to...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 22; no. 9; p. 1490
Main Authors Demir Özkay, Ümide, Kaya, Ceren, Acar Çevik, Ulviye, Can, Özgür Devrim
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 07.09.2017
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Within the scope of our new antidepressant drug development efforts, in this study, we synthesized eight novel benzothiazole derivatives - . The chemical structures of the synthesized compounds were elucidated by spectroscopic methods. Test compounds were administered orally at a dose of 40 mg/kg to mice 24, 5 and 1 h before performing tail suspension, modified forced swimming, and activity cage tests. The obtained results showed that compounds , , - reduced the immobility time of mice as assessed in the tail suspension test. Moreover, in the modified forced swimming tests, the same compounds significantly decreased the immobility, but increased the swimming frequencies of mice, without any alteration in the climbing frequencies. These results, similar to the results induced by the reference drug fluoxetine (20 mg/kg, po), indicated the antidepressant-like activities of the compounds , , - . Owing to the fact that test compounds did not induce any significant alteration in the total number of spontaneous locomotor activities, the antidepressant-like effects of these derivatives seemed to be specific. In order to predict ADME parameters of the synthesized compounds - , some physicochemical parameters were calculated. The ADME prediction study revealed that all synthesized compounds may possess good pharmacokinetic profiles.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules22091490